| 发明名称 |
INHIBITION OF SARS CORONAVIRUS INFECTION WITH CLINICALLY APPROVED ANTIVIRAL DRUGS |
| 摘要 |
The invention relates to methods for treating or inhibiting SARS-CoV infecti on involving the administration of an interferon, particularly IFN .alpha.-n1, IFN .alpha.-n3, human leukocyte IFN .alpha. or IFN .beta.-1b.
|
| 申请公布号 |
CA2527711(A1) |
申请公布日期 |
2004.12.16 |
| 申请号 |
CA20042527711 |
申请日期 |
2004.06.09 |
| 申请人 |
GENOME INSTITUTE OF SINGAPORE |
发明人 |
TAN, EMILY LI CHUAN;STANTON, LAWRENCE W. |
| 分类号 |
A61K38/21;A61K31/4196;A61P11/00 |
主分类号 |
A61K38/21 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
